Correction: Corrigendum: Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients

Correction: Corrigendum: Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients

Nature Communications 7: Article number: 11815 (2016); Published 10 June 2016; Updated 14 November 2016 Previous work by Del Re et al. describing the emergence of KRAS mutations following treatment of non-small cell lung cancer patients with EGFR tyrosine kinase inhibitors was inadvertently omitted...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jacob J. Chabon, Andrew D. Simmons, Alexander F. Lovejoy, Mohammad S. Esfahani, Aaron M. Newman, Henry J. Haringsma, David M. Kurtz, Henning Stehr, Florian Scherer, Chris A. Karlovich, Thomas C. Harding, Kathleen A. Durkin, Gregory A. Otterson, W. Thomas Purcell, D. Ross Camidge, Jonathan W. Goldman, Lecia V. Sequist, Zofia Piotrowska, Heather A. Wakelee, Joel W. Neal, Ash A. Alizadeh, Maximilian Diehn
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2016
Materias:
Science
Q
Acceso en línea:https://doaj.org/article/fbfbad6d408d474fbf2dbbd76eda64e4
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:fbfbad6d408d474fbf2dbbd76eda64e4
record_format dspace
spelling oai:doaj.org-article:fbfbad6d408d474fbf2dbbd76eda64e42021-12-02T17:32:53ZCorrection: Corrigendum: Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients10.1038/ncomms135132041-1723https://doaj.org/article/fbfbad6d408d474fbf2dbbd76eda64e42016-11-01T00:00:00Zhttps://doi.org/10.1038/ncomms13513https://doaj.org/toc/2041-1723Nature Communications 7: Article number: 11815 (2016); Published 10 June 2016; Updated 14 November 2016 Previous work by Del Re et al. describing the emergence of KRAS mutations following treatment of non-small cell lung cancer patients with EGFR tyrosine kinase inhibitors was inadvertently omitted from the reference list of this Article and should have been cited as follows.Jacob J. ChabonAndrew D. SimmonsAlexander F. LovejoyMohammad S. EsfahaniAaron M. NewmanHenry J. HaringsmaDavid M. KurtzHenning StehrFlorian SchererChris A. KarlovichThomas C. HardingKathleen A. DurkinGregory A. OttersonW. Thomas PurcellD. Ross CamidgeJonathan W. GoldmanLecia V. SequistZofia PiotrowskaHeather A. WakeleeJoel W. NealAsh A. AlizadehMaximilian DiehnNature PortfolioarticleScienceQENNature Communications, Vol 7, Iss 1, Pp 1-1 (2016)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
Jacob J. Chabon
Andrew D. Simmons
Alexander F. Lovejoy
Mohammad S. Esfahani
Aaron M. Newman
Henry J. Haringsma
David M. Kurtz
Henning Stehr
Florian Scherer
Chris A. Karlovich
Thomas C. Harding
Kathleen A. Durkin
Gregory A. Otterson
W. Thomas Purcell
D. Ross Camidge
Jonathan W. Goldman
Lecia V. Sequist
Zofia Piotrowska
Heather A. Wakelee
Joel W. Neal
Ash A. Alizadeh
Maximilian Diehn
Correction: Corrigendum: Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients
description Nature Communications 7: Article number: 11815 (2016); Published 10 June 2016; Updated 14 November 2016 Previous work by Del Re et al. describing the emergence of KRAS mutations following treatment of non-small cell lung cancer patients with EGFR tyrosine kinase inhibitors was inadvertently omitted from the reference list of this Article and should have been cited as follows.
format article
author Jacob J. Chabon
Andrew D. Simmons
Alexander F. Lovejoy
Mohammad S. Esfahani
Aaron M. Newman
Henry J. Haringsma
David M. Kurtz
Henning Stehr
Florian Scherer
Chris A. Karlovich
Thomas C. Harding
Kathleen A. Durkin
Gregory A. Otterson
W. Thomas Purcell
D. Ross Camidge
Jonathan W. Goldman
Lecia V. Sequist
Zofia Piotrowska
Heather A. Wakelee
Joel W. Neal
Ash A. Alizadeh
Maximilian Diehn
author_facet Jacob J. Chabon
Andrew D. Simmons
Alexander F. Lovejoy
Mohammad S. Esfahani
Aaron M. Newman
Henry J. Haringsma
David M. Kurtz
Henning Stehr
Florian Scherer
Chris A. Karlovich
Thomas C. Harding
Kathleen A. Durkin
Gregory A. Otterson
W. Thomas Purcell
D. Ross Camidge
Jonathan W. Goldman
Lecia V. Sequist
Zofia Piotrowska
Heather A. Wakelee
Joel W. Neal
Ash A. Alizadeh
Maximilian Diehn
author_sort Jacob J. Chabon
title Correction: Corrigendum: Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients
title_short Correction: Corrigendum: Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients
title_full Correction: Corrigendum: Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients
title_fullStr Correction: Corrigendum: Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients
title_full_unstemmed Correction: Corrigendum: Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients
title_sort correction: corrigendum: circulating tumour dna profiling reveals heterogeneity of egfr inhibitor resistance mechanisms in lung cancer patients
publisher Nature Portfolio
publishDate 2016
url https://doaj.org/article/fbfbad6d408d474fbf2dbbd76eda64e4
work_keys_str_mv AT jacobjchabon correctioncorrigendumcirculatingtumourdnaprofilingrevealsheterogeneityofegfrinhibitorresistancemechanismsinlungcancerpatients
AT andrewdsimmons correctioncorrigendumcirculatingtumourdnaprofilingrevealsheterogeneityofegfrinhibitorresistancemechanismsinlungcancerpatients
AT alexanderflovejoy correctioncorrigendumcirculatingtumourdnaprofilingrevealsheterogeneityofegfrinhibitorresistancemechanismsinlungcancerpatients
AT mohammadsesfahani correctioncorrigendumcirculatingtumourdnaprofilingrevealsheterogeneityofegfrinhibitorresistancemechanismsinlungcancerpatients
AT aaronmnewman correctioncorrigendumcirculatingtumourdnaprofilingrevealsheterogeneityofegfrinhibitorresistancemechanismsinlungcancerpatients
AT henryjharingsma correctioncorrigendumcirculatingtumourdnaprofilingrevealsheterogeneityofegfrinhibitorresistancemechanismsinlungcancerpatients
AT davidmkurtz correctioncorrigendumcirculatingtumourdnaprofilingrevealsheterogeneityofegfrinhibitorresistancemechanismsinlungcancerpatients
AT henningstehr correctioncorrigendumcirculatingtumourdnaprofilingrevealsheterogeneityofegfrinhibitorresistancemechanismsinlungcancerpatients
AT florianscherer correctioncorrigendumcirculatingtumourdnaprofilingrevealsheterogeneityofegfrinhibitorresistancemechanismsinlungcancerpatients
AT chrisakarlovich correctioncorrigendumcirculatingtumourdnaprofilingrevealsheterogeneityofegfrinhibitorresistancemechanismsinlungcancerpatients
AT thomascharding correctioncorrigendumcirculatingtumourdnaprofilingrevealsheterogeneityofegfrinhibitorresistancemechanismsinlungcancerpatients
AT kathleenadurkin correctioncorrigendumcirculatingtumourdnaprofilingrevealsheterogeneityofegfrinhibitorresistancemechanismsinlungcancerpatients
AT gregoryaotterson correctioncorrigendumcirculatingtumourdnaprofilingrevealsheterogeneityofegfrinhibitorresistancemechanismsinlungcancerpatients
AT wthomaspurcell correctioncorrigendumcirculatingtumourdnaprofilingrevealsheterogeneityofegfrinhibitorresistancemechanismsinlungcancerpatients
AT drosscamidge correctioncorrigendumcirculatingtumourdnaprofilingrevealsheterogeneityofegfrinhibitorresistancemechanismsinlungcancerpatients
AT jonathanwgoldman correctioncorrigendumcirculatingtumourdnaprofilingrevealsheterogeneityofegfrinhibitorresistancemechanismsinlungcancerpatients
AT leciavsequist correctioncorrigendumcirculatingtumourdnaprofilingrevealsheterogeneityofegfrinhibitorresistancemechanismsinlungcancerpatients
AT zofiapiotrowska correctioncorrigendumcirculatingtumourdnaprofilingrevealsheterogeneityofegfrinhibitorresistancemechanismsinlungcancerpatients
AT heatherawakelee correctioncorrigendumcirculatingtumourdnaprofilingrevealsheterogeneityofegfrinhibitorresistancemechanismsinlungcancerpatients
AT joelwneal correctioncorrigendumcirculatingtumourdnaprofilingrevealsheterogeneityofegfrinhibitorresistancemechanismsinlungcancerpatients
AT ashaalizadeh correctioncorrigendumcirculatingtumourdnaprofilingrevealsheterogeneityofegfrinhibitorresistancemechanismsinlungcancerpatients
AT maximiliandiehn correctioncorrigendumcirculatingtumourdnaprofilingrevealsheterogeneityofegfrinhibitorresistancemechanismsinlungcancerpatients
_version_ 1718380161664024576

Ejemplares similares